Design and in vitro evaluation of haloperidol lactate transdermal patches containing ethyl cellulose-povidone as film formers

Article Sidebar

PDF
Published: Aug 28, 2014
DOI: https://doi.org/10.22377/ajp.v2i1.173

Main Article Content

R Sadashivaiah
B M Dinesh
Uma A Patil
K S Raghu

Abstract

Matrix-type transdermal drug delivery systems of haloperidol lactate were prepared using different ratios of ethyl cellulose (EC):polyvinyl pyrrolidone (PVP) (3:2, 2:3, 4:1, 1:2, 2:1, and 1:4) by solvent-evaporation technique.
Physicochemical parameters were characterized, and dissolution studies of the formulated films were performed. In addition, solubility studies at various values of pH were carried out, and partition coefficient in octanol/water system, flux, and enhancement ratio were also evaluated. In vitro permeation studies were done using modified Franz diffusion cells through human cadaver skin utilizing 20% PEG 400 in normal saline. Permeation studies illustrated that 4% hyaluronidase enzyme was a good enhancer. The prepared films were subjected to scanning electron microscopy (SEM) and fourier transform infrared spectroscopy (FT-IR) spectral analysis. Higuchi and Peppas models were used for optimizing the formulation.

Downloads

Download data is not yet available.

Article Details

How to Cite
Sadashivaiah, R., Dinesh, B. M., Patil, U. A., & Raghu, K. S. (2014). Design and in vitro evaluation of haloperidol lactate transdermal patches containing ethyl cellulose-povidone as film formers. Asian Journal of Pharmaceutics (AJP), 2(1). https://doi.org/10.22377/ajp.v2i1.173
Issue
Vol. 2 No. 1 (2008): Jan-Mar
Section
Articles

This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.

References

Howells JG. The Concept of Schizophrenia Historical Perspectives. 1st ed.

Washington: American Psychiatric Press; 1991. p. 18.

Hardman JG, Limbird LE. Goodman and Gilman’s the pharmacological

basis of therapeutics. 10th ed. New Delhi: McGraw Hill Medical

Publishing Division; 2001. p. 496.

Lec ST, Yak SH, Kim SW, Berner B. One way membrane for transdermal

drug delivery systems/system optimization. Int J Pharm 1991;77:231-7.

Krishnaiah YS, Satyanarayana V, Karthikeyan RS. Effect of the solvent

system on the In vitro permeability of Nicardipine hydrochloride through

excised rat epidermis. Indian J Pharm Sci 2002;5:124-30.

Sutariya V, Mashru R, Sunkalia MS. Transbuccal delivery of lomotrigine

across procine buccal mucosa invitro determination of roots of buccal

transport. J Pharm Sci 2005;8:54-62.

Mashru R, Sutariya V, Sankalia M, Sankalia J. Transbuccaldelivery of

lamotrigine across porcine buccal mucosa: In vitro determination of

routes of buccal transport. Pharm Pharma Sci 2005;8:54-62.

Shah JC, Ross JS. Reduction in skin permeation of n,n-diethyl-m-

toluamide by altering the skin/vehicle partition co-efficient. J Control

Release 2000;67:211-21.

Pugh WJ, Hadgraft J. Prediction of human skin permeability coefficients.

Int J Pharm 1994;103:163-78.

Hsieh DS. Drug permeation enhancement. Vol.62. New York: Marcel

Dekker; 1994. p. 47.

Deasy PB, McDaid DM. Formulation development of a transdermal drug

delivery system for Amlodipine base. Int J Pharm 1996;133:71-83.

Jain NK. Advances in controlled and novel drug delivery. 1st ed. New

Delhi: CBS Publishers; 2001. p. 108.

Koteswar UN. Preparation and evaluation of captopril transdermal

matrices. Indian Drugs 1992;29:680-8.

Udupa N, Pandey N, Praveen SH. Formulation and evaluation of

Nimesulide transdermal drug delivery systems. Indian J Pharm Sci

;62:376-9.

Ghosal SK, Bhattacharya M, Mandal SC. Invitro release and permeation kinetics of pentazocaine from matrix dispersion type transdermal drug delivery systems. Drug Dev Ind Pharm 1994;20:1933-41.